A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells

BACKGROUND: Targeting Signal Transducer and Activator of Transcription 3 (STAT3) signaling is an attractive therapeutic approach for most types of human cancers with constitutively activated STAT3. A novel small molecular STAT3 inhibitor, FLLL32 was specifically designed from dietary agent, curcumin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Li, Deangelis, Stephanie, Foust, Elizabeth, Fuchs, James, Li, Chenglong, Li, Pui-Kai, Schwartz, Eric B, Lesinski, Gregory B, Benson, Don, Lü, Jiagao, Hoyt, Dale, Lin, Jiayuh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936338/
https://www.ncbi.nlm.nih.gov/pubmed/20712901
http://dx.doi.org/10.1186/1476-4598-9-217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936338/
https://www.ncbi.nlm.nih.gov/pubmed/20712901
http://dx.doi.org/10.1186/1476-4598-9-217

Ejemplares similares